Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study. Transl Psychiatry. 2026 16(1):226. Epub 2026 Mar 31.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study. Lancet Psychiatry. 2026 13(8):669-677.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study. Lancet Reg Health Eur. 2026 65:101658.
Ghadami A, Sreepada A, Reinhard I, Ganz M, Boehmer J, Meyer-Degering K, Walter H, Andoh J, Lenz B, Bach P, Kiefer F, Schwarz E, Reichert M, Ebner-Priemer UW, Meyer-Lindenberg A, Heim C, Tost H. Real-world alcohol cue exposure and drinking risk in alcohol use disorder. Transl Psychiatry. 2026 16(1)
Rötzer L, Zaiser J, Hoffmann S, Hiß I, Reinhard I, Heim C, Tost H, Kiefer F, Lenz B, Bach P. Sex-Moderated and Sex-Specific Effects of Adverse Childhood Experiences on Neural Alcohol Cue Reactivity and Daily Craving in Individuals With Alcohol Use Disorder. Am J Psychiatry. 2026 Sep 9. [Epub ahead of print]